Psyence Biomedical Ltd. - Ordinary Shares (PBM)
7.0300
-2.1200 (-23.17%)
NASDAQ · Last Trade: Jul 29th, 6:38 PM EDT
Via Benzinga · July 28, 2025
Via Benzinga · July 24, 2025
Via Benzinga · June 17, 2025
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · May 1, 2025
Via Benzinga · May 1, 2025
Via Benzinga · April 8, 2025
Via Benzinga · March 31, 2025

Via Benzinga · December 23, 2024

Via Benzinga · December 20, 2024

Via Benzinga · December 20, 2024

U.S. futures declined on Friday, ahead of the 'Triple Witching' hour, which is expected to see $6.6 trillion options expire, for the quarter.
Via Benzinga · December 20, 2024

Via Benzinga · December 19, 2024

Via Benzinga · December 10, 2024

Via Benzinga · December 9, 2024

Via Benzinga · December 6, 2024

Via Benzinga · December 5, 2024

Via Benzinga · December 5, 2024

Psyence Biomed secures Nasdaq extension to meet compliance by December 31, advancing psilocybin-based therapeutics for mental health treatments.
Via Benzinga · November 20, 2024

Via Benzinga · November 13, 2024

Via Benzinga · November 7, 2024